RecruitingNot ApplicableNCT06441786

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism: Feasibility, Acceptability and Effect in a Clinical Open Trial

Sponsor

Uppsala University

Enrollment

36 participants

Start Date

Aug 12, 2024

Study Type

INTERVENTIONAL

Conditions

Anxiety Depression

Summary

The goal of this open clinical trial is to try out and evaluate a group metacognitive treatment protocol, for adolescents aged 15-18 years of age with anxiety and/or depression and an autism diagnosis. The main questions it aims to answer are: 1. How does the recruitment to the study work and what is the retention rate? 2. What is the level of participant compliance? 3. Is the treatment adherence satisfactory, are there any practical problems with treatment delivery? 4. Are the outcome measures and assessment procedures feasible? 5. Do the participants accept the treatment, are there any reports of adverse effects? 6. What are the preliminary effects of the treatment regarding 1. Symptoms of anxiety and/or depression 2. Quality of life 3. Functional impairment 4. Subjective level of stress 5. Central metacognitive processes 7. Are changes in metacognitive processes related to changes in anxiety and depression? The participants will partake in metacognitive group treatment of 10 sessions following an initial screening.

Eligibility

Min Age: 15 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a group therapy approach called Metacognitive Therapy (MCT) — which helps people change the way they think about their own thoughts and worries — for teenagers with autism who also have anxiety or depression. The therapy is delivered in a group setting at a psychiatric clinic in Stockholm. **You may be eligible if...** - You are between 15 and 18 years old - You are seeking care at the PRIMA psychiatric clinic in Stockholm - You have a diagnosis of both autism AND either an anxiety disorder or depression - You understand Swedish well enough to participate in therapy - You and your guardians are willing and able to participate **You may NOT be eligible if...** - You do not have both autism and a co-existing anxiety or depression diagnosis - You do not speak or understand Swedish adequately - You have another condition that makes group therapy unsuitable Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALA metacognitive group therapy of depression and anxiety in youth with autism

The treatment model is based on Adrian Wells' transdiagnostic A-M-C model and treatment structure described in Wells (2009) "Metacognitive therapy for anxiety and depression". The group treatment is delivered in 10 weekly sessions.

Locations(1)

PRIMA Child and Youth Psychiatry, Handen

Haninge, Stockholm County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06441786

Related Trials

The Effect of Using Weighted Blanket on Anxiety, Stress, Depression and Comfort Level Among Patients With Cancer Undergoing Intravenous Anticancer Therapy and Its Feasibility of Use by Nurses Compared to Routine Care

NCT076530351 location

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

NCT071435396 locations